BiotechTube
Home/Orca Bio/Mike Hirschmann
MH

Mike Hirschmann

Commercial

Orca Bio

Therapeutic Areas

OncologyAutoimmune Diseases

Orca Bio Pipeline

DrugIndicationPhase
Orca-Q (inferred)High-risk blood cancers (AML, ALL, MDS)Phase 3

Leadership Team at Orca Bio

NF
Nate Fernhoff, PhD
Co-founder and Chief Executive Officer
JB
Jeroen Bekaert, PhD
Co-founder and President
AF
Allison Frisbee
Legal
View full Orca Bio profile